What is the average duration of resistance to lorlatinib?
Exact data on the mean duration of resistance to lorlatinib (Lorlatinib) in patients with non-small cell lung cancer (NSCLC) may be updated as a result of new clinical trials and studies. However, early clinical trial data suggest that lorlatinib is effective in treating ALK (tyrosine kinase) and ROS1 (
In some key clinical trials, lorlatinib has shown significant efficacy in ALKpositiveNSCLC patients, with PFS improved compared to traditional ALK inhibitors. A clinical trial of lorlatinib in patients with NSCLC who had developed resistance to previously treated ALK inhibitors (e.g., NCT01970865) showed positive results in this patient subpopulation. However, the specific mean duration of resistance varies with individual differences and study design.

It should be noted that the resistance time may be affected by a variety of factors, including the patient's genetic mutation, the molecular characteristics of the disease, and monitoring strategies before and after treatment. During long-term treatment, some patients may develop resistance to lorlatinib, which is one of the common challenges faced by targeted therapies.
With further research and continued clinical practice, we can expect more detailed information on lorlatinib resistance, which will help to better understand and manage patient response to treatment.
Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. Please consult the local hospital pharmacy for details. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)